$161.20
1.771.11%
가까이에: Nov 20, 4:00 PM EST
$165.32
4.122.56%
시간외: 7:28 PM EST

Revolution Medicines (RVMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-1.90 | $-2.37 | 19.8 % |
| Q2 | Aug 5, 2026 | $-3.06 | $-2.01 | -52.2 % |
| Q1 | May 6, 2026 | $-2.29 | $-1.84 | -24.5 % |
| Q4 | Feb 25, 2026 | $-1.86 | $-1.56 | -19.2 % |
Quarterly Revenue (Billions)
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $197.56M | $27.55M | 617.0 % |
| Q2 | Aug 5, 2026 | $0 | $39.73M | -100.0 % |
| Q1 | May 6, 2026 | $0 | $6.10M | -100.0 % |
| Q4 | Feb 25, 2026 | $0 | $11.58M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.37 | $-2.01 | $-1.84 | $-1.56 |
| Actual | $-1.90 | $-3.06 | $-2.29 | $-1.86 |
| Surprise | +19.8% | -52.2% | -24.5% | -19.2% |
| Revenue | ||||
| Estimate | $27.6M | $39.7M | $6.1M | $11.6M |
| Actual | $197.6M | $0 | $0 | $0 |
| Surprise | +617.0% | -100.0% | -100.0% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.11 | $-0.82 | $-0.76 | $-0.71 |
| Revenue | ||||
| Consensus | $412.5M | $465.2M | — | — |